Drug Type Small molecule drug |
Synonyms 625433, GSK 625433, GSK625433 |
Target |
Mechanism NS5B polymerase inhibitors(Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC26H32N4O5S |
InChIKeyHLQXYDHLDZTWDW-COMFIFEGSA-N |
CAS Registry885264-71-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C, Chronic | Phase 1 | US | 01 Oct 2006 |